The Supreme Court on Thursday maintained access to the abortion pill mifepristone, rebuffing attempts from anti-abortion groups to roll back policies that have made it easier to obtain the widely used drug. In a unanimous ruling, the court said that several anti-abortion doctors and groups do not have legal standing to challenge the Food and Drug Administration's decisions in 2016 and 2021 to relax various regulatory requirements around the drug. Read the latest
|